These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9161517

  • 1. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP.
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract] [Full Text] [Related]

  • 2. [Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
    Pawlotsky JM.
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S41-50. PubMed ID: 9161513
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic viral hepatitis].
    Marcellin P, Metreau JM, Pol S, Zoulim F.
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract] [Full Text] [Related]

  • 4. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M, Golstein P, Botembe N, Bourgeois N.
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [Abstract] [Full Text] [Related]

  • 5. Managing patients with hepatitis C.
    Drug Ther Bull; 1993 Aug 02; 31(16):61-2. PubMed ID: 8375275
    [No Abstract] [Full Text] [Related]

  • 6. Hepatitis C. The surprise infectious disease of the decade.
    Mayo Clin Health Lett; 1998 Feb 02; 16(2):6. PubMed ID: 9516363
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT.
    Clin Liver Dis; 2005 Aug 02; 9(3):473-86, viii. PubMed ID: 16023978
    [Abstract] [Full Text] [Related]

  • 8. [Should hepatitis C be treated?].
    Tran A.
    Gastroenterol Clin Biol; 1997 Aug 02; 21(1 Pt 2):S148-53. PubMed ID: 9161526
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG, Kuznetsov SL, Liuliaeva OD, Storozhakov GI, Kisliakov VA, Uskov IuI.
    Klin Med (Mosk); 1998 Aug 02; 76(8):33-5. PubMed ID: 9770965
    [Abstract] [Full Text] [Related]

  • 10. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
    Degos F.
    Gastroenterol Clin Biol; 1997 Aug 02; 21(1 Pt 2):S57-65. PubMed ID: 9161515
    [No Abstract] [Full Text] [Related]

  • 11. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
    Payen JL.
    Gastroenterol Clin Biol; 1997 Aug 02; 21(1 Pt 2):S175-89. PubMed ID: 9161529
    [No Abstract] [Full Text] [Related]

  • 12. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D.
    Gastroenterol Clin Biol; 1997 Aug 02; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract] [Full Text] [Related]

  • 13. Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy.
    Ono SK, da Silva LC, Carrilho FJ, da Fonseca LE, Mendes LC, Madruga CL, Farias Ade Q, Laudanna AA.
    Rev Hosp Clin Fac Med Sao Paulo; 1996 Aug 02; 51(5):180-3. PubMed ID: 9216095
    [Abstract] [Full Text] [Related]

  • 14. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P.
    Gastroenterol Clin Biol; 1997 Aug 02; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct 02; 7(37):150-4. PubMed ID: 10915423
    [Abstract] [Full Text] [Related]

  • 16. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U, Niederau C, Kleber G, Fleig WE.
    Z Gastroenterol; 1997 Nov 02; 35(11):971-86. PubMed ID: 9490556
    [No Abstract] [Full Text] [Related]

  • 17. Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
    Morosetti M, Sciarra G, Meloni C, Palmieri G, Palombo G, Taccone Gallucci M, Casciani CU.
    Nephrol Dial Transplant; 1996 Mar 02; 11(3):532-4. PubMed ID: 8671827
    [No Abstract] [Full Text] [Related]

  • 18. [Chronic hepatitis C: therapeutic uncertainties].
    Blondon H, Bergmann JF.
    Gastroenterol Clin Biol; 1996 Mar 02; 20(12):1043-6. PubMed ID: 9033847
    [No Abstract] [Full Text] [Related]

  • 19. Interferon alpha in hepatitis C: a cytokine for reducing fibrosis progression.
    Poynard T.
    Eur Cytokine Netw; 1997 Sep 02; 8(3):319-20. PubMed ID: 9346374
    [No Abstract] [Full Text] [Related]

  • 20. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M, Yanaga K, Morizane T, Yanagawa T, Hirakawa M, Ueno Y, Esquivel CO, Mitamura K.
    J Gastroenterol; 2003 Sep 02; 38(6):598-602. PubMed ID: 12858850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.